 NEW YORK and CLEVELAND, April 20, 2021 GLOBE NEWSWIRE -- Abeona Therapeutics Inc. Nasdaq: ABEO, a fully-integrated leader in gene and cell therapy, today announced that new data from its preclinical research will be highlighted during an oral presentation at the Association for Research in Vision and Ophthalmology ARVO 2021 Annual Meeting, being held virtually from May 1-7, 2021. 